Combining EGFR and MET inhibition with crizotinib in EGFR-mutated lung adenocarcinoma harboring MET amplification: a brief report
2020
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
25
References
2
Citations
NaN
KQI